{
  "docId": "019de077-5eda-7429-9622-6655c69874f4",
  "docSlug": "189ccbf1ac7d3b2805c8850962309310",
  "documentTitle": "Legend Biotech | Results Presentation Deck | 17 slides",
  "authorId": "legend-biotech",
  "authorName": "Legend Biotech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 17,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-5eda-7429-9622-6655c69874f4/5",
  "deckHref": "/decks/019de077-5eda-7429-9622-6655c69874f4",
  "deckJsonHref": "/decks/019de077-5eda-7429-9622-6655c69874f4.json",
  "deckAnchorHref": "/decks/019de077-5eda-7429-9622-6655c69874f4#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.02,
        "w": 0.4,
        "x": 0.1,
        "y": 0.95
      },
      "kind": "disclaimer",
      "text": "This presentation is for investor relations purposes only - Not for product promotional purposes",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "811a986d-5fd2-4a4c-89ff-d00b560df66e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.22,
        "x": 0.56,
        "y": 0.28
      },
      "kind": "list",
      "text": "Unlocking value across our broader pipeline: Advance early-stage candidates; Phase 1 trial for autoimmune program; new R&D facility in Philadelphia.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5043c328-92e9-458e-8bd7-5c66a3ece127",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.22,
        "x": 0.06,
        "y": 0.28
      },
      "kind": "list",
      "text": "Establishing a strong foundation for CARVYKTI® market penetration: 3Q24 net trade sales of $286MM; Long-Term Overall Survival Data; label expansion in Switzerland; 4L+ approval in China; launch in Switzerland; 4,000+ patients treated; Alan Bash appointed.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "583a7543-1729-47c1-85a9-c7782c3c66e7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.17,
        "x": 0.81,
        "y": 0.28
      },
      "kind": "list",
      "text": "Maintaining a solid financial position to fund sustainable growth: $1.2 billion cash position; funding into 2026; GenScript deconsolidation.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a20bb341-bfae-48f0-8c2b-b5fcb486f6bc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.22,
        "x": 0.31,
        "y": 0.28
      },
      "kind": "list",
      "text": "Strengthening our manufacturing capabilities: Approval and initiation of commercial production at Obelisc site; progress on Raritan site expansion.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cd94435d-ea31-49cd-aac7-2116a980a504",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.58,
        "x": 0.21,
        "y": 0.21
      },
      "kind": "title",
      "text": "CONTINUED PROGRESS AGAINST OUR STRATEGIC PRIORITIES",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3482bf7c-01e9-4fdb-a694-6123f671a1bd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.08,
        "y": 0.05
      },
      "kind": "title",
      "text": "Business Highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "af6b589b-ac09-4d22-9398-0e0548913c2a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "620c9206-3633-4938-80d0-790a09d4396d",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Interest",
      "beatSlug": "aida-interest",
      "evidence": "The key takeaways slide highlights the company's progress.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}